Aleph FarmsVBL TherapeuticsESCO Aster
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Slightly above 62% of Vascular Biogenics' investor base is looking to short. The analysis of current outlook of investing in Vascular Biogenics suggests that many traders are alarmed regarding Vascular Biogenics' prospects. Vascular Biogenics' investing sentiment can be driven by a variety of factors including economic data, Vascular Biogenics' earnings reports, geopolitical events, and overall market trends.
Vascular |
--Aleph FarmsVBL Therapeutics Aleph FarmsESCO Ast
Read at businesswire.com
 |
Vascular Biogenics Fundamental Analysis
We analyze Vascular Biogenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Vascular Biogenics is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Vascular Biogenics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vascular Biogenics stock to make a market-neutral strategy. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics with similar companies.
Peers
Vascular Biogenics Related Equities
| ABOS | Acumen Pharmaceuticals | 7.36 | ||||
| TERN | Terns Pharmaceuticals | 4.94 | ||||
| VRAX | Virax Biolabs | 2.39 | ||||
| DAWN | Day One | 1.14 | ||||
| ZURA | Zura Bio | 1.13 | ||||
| RNAZ | Transcode Therapeutics | 0.85 | ||||
| HOOK | Hookipa Pharma | 2.45 | ||||
| INZY | Inozyme Pharma | 3.70 | ||||
| ALLR | Allarity Therapeutics | 3.81 | ||||
| XFOR | X4 Pharmaceuticals | 3.92 | ||||
| ZVSA | ZyVersa Therapeutics | 5.41 | ||||
| ATXI | Avenue Therapeutics | 6.49 | ||||
| PHIO | Phio Pharmaceuticals | 7.66 | ||||
| REVB | Revelation Biosciences | 14.63 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |